CClinicalTrials.gg
Status unknownNCT04734314Updated Feb 8, 2021

Efficacy of Vojta on Balance and Quality of Life in Subject With CNLBP

An interventional study of conventional physical therapy and vojta therapy in Chronic Non-Specific Low Back Pain, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-08.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Apr 2020, registered Jan 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

. To investigate the effect of Vojta method on static balance ,dynamic balance, quality of life in patients with chronic non - specific low back pain

Read the detailed description

This randomized controlled trial is to investigate the effect of Vojta method on balance and quality of life in patients with chronic non-specific low back pain.

Forty patients (male and female) complaining of chronic non -specific low back pain was recruited to share in this study

. The recruited patients were randomly recruited into two groups; group A (control group) and group B (study group).

Group A: received conventional treatment of back pain which included; TENS 20 min and hot packs 10 min .The total treatment session is 30 min three session per week for four weeks Group B: received conventional treatment of back pain in addition to Vojta method. The total treatment session is 40 min.

Patient in both groups performed 10 sessions, 3 session per week

02

Conditions studied

  • Chronic Non-Specific Low Back Pain
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's planned enrollment of 45 is below the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Patients with chronic non -specific low back pain for more than 3 months.
  2. Their age ranged between 18-35 years old
  3. Both sexes were recruited in this study.
  4. Their BMI ranged between 18-25 kg/m2

Exclusion criteria

Exclusion Criteria:

1- Patients with previous spinal surgery 2. Patients who have radiological diagnosis of spondylolysis or spondylolisthesis.

  1. Patient with neurological disease . 4. Chest problems 5. Systematic disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    conventional treatment of back pain

    Group A: received conventional treatment of back pain which included; TENS 20 min and hot packs 10 min .The total treatment session is 30 min three session per week for four weeks

    Other: conventional physical therapy

  • Experimental
    vojta therapy

    received conventional treatment of back pain in addition to Vojta therapy . The total treatment session is 40 min.

    Other: conventional physical therapy · Other: vojta therapy

Interventions

  • Otherconventional physical therapy

    conventional physical therapy in the form of transcutaneous electrical stimulation (TENS) for 20 min and hot pack for 10 min Each patient received 12 sessions three session per week.

  • Othervojta therapy

    Vojta Dynamic Neuromuscular Stabilization (DNS) is a therapy used to manage neurological and musculoskeletal conditions each patient in the study group (group B) was instructed to lie prone on an examination table with the participant's shoulders abducted, elbows flexed approximately 80-90°, and the forearms hanging off the edge of the table. Pressure-like stimulation of the calcaneus and ASIS were performed in the postural position named by Vojta as "reflex creeping. Each patient received 12 sessions three session per week.

06

What researchers measure

Primary outcomes

  1. static and dynamic balance

    static and dynamic balance can assessed by using biodex balance system Each patient was instructed to maintain his/her balance for the period of the test. There was report gained after finishing every test includes information on medial lateral stability index(MLSI), overall stability index(OSI), and anterior posterior stability index (APSI) measurements will done twice before and after treatment for all patients in both group

    Time frame: one month

  2. Oswestry Low Back Pain Disability Questionnaire

    The Oswestry Low Back Pain Disability Questionnaire is an extremely important tool that researchers and disability evaluators use to measure a patient's permanent functional disability and quality of life. The test is considered the 'gold standard' of low back functional outcome tools measurements will done twice before and after treatment for all patients in both group

    Time frame: one month

07

Study locations

1 of 1 sites recruiting
  • Mti University
    Cairo, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04734314
Lead sponsor
Cairo University
Responsible party
walaa (principle investigator, MTI University) — Principal investigator
First posted
Feb 2, 2021
Start date
Apr 1, 2020
Primary completion
Feb 5, 2021 (estimated)
Completion
Feb 5, 2021 (estimated)
Last update
Feb 8, 2021

Study contacts

walaa mohamed, B.Sc
Contact
dr-walaamohamed@hotmail.com
01115640229

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion